OneAscent Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305K Sell
2,192
-83
-4% -$11.6K 0.1% 111
2025
Q4
$279K Sell
2,275
-62
-3% -$7.54K 0.09% 122
2025
Q3
$259K Sell
2,337
-49
-2% -$5.57K 0.09% 140
2025
Q2
$265K Buy
2,386
+149
+7% +$15.9K 0.1% 132
2025
Q1
$251K Hold
2,237
0.11% 121
2024
Q4
$207K Sell
2,237
-189
-8% -$17K 0.09% 153
2024
Q3
$203K Buy
+2,426
New +$185K 0.08% 174
2024
Q1
Sell
-3,609
Closed -$292K 183
2023
Q4
$292K Sell
3,609
-243
-6% -$18.9K 0.12% 123
2023
Q3
$289K Buy
+3,852
New +$296K 0.13% 112
2023
Q2
Sell
-4,478
Closed -$372K 137
2023
Q1
$372K Sell
4,478
-732
-14% -$60.6K 0.14% 91
2022
Q4
$447K Sell
5,210
-1,776
-25% -$141K 0.21% 57
2022
Q3
$431K Buy
6,986
+12
+0.2% +$757 0.23% 47
2022
Q2
$431K Buy
6,974
+323
+5% +$20K 0.22% 64
2022
Q1
$395K Buy
+6,651
New +$425K 0.2% 107
2021
Q1
$686K Buy
10,607
+366
+4% +$23.6K 0.29% 76
2020
Q4
$597K Buy
+10,241
New +$618K 0.27% 82

Other funds holding GILD

OneAscent Wealth Management's GILD Position: Q1 2026 in Review

OneAscent Wealth Management reduced its Gilead Sciences (GILD) stake by 3.6% in Q1 2026, selling an estimated $11.6K and leaving 2,192 shares worth $305K. The position accounts for 0.1% of the portfolio, ranked #111.

OneAscent Wealth Management first reported a position in GILD in Q4 2020 and has held it in 16 quarters since. The position peaked at $686K in Q1 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • OneAscent Wealth Management held 2,192 shares of Gilead Sciences worth $305K as of Q1 2026.
  • OneAscent Wealth Management sold 83 Gilead Sciences shares in Q1 2026, an estimated $11.6K.
  • Gilead Sciences made up 0.1% of OneAscent Wealth Management's portfolio in Q1 2026, its #111 holding.
  • OneAscent Wealth Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 16 quarters since.
  • OneAscent Wealth Management's Gilead Sciences position peaked at $686K in Q1 2021.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on OneAscent Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.